NewsDialy

Delphia Therapeutics Names David Kerstein as Chief Medical Officer

6/26/2026

Delphia Therapeutics has appointed David Kerstein as its chief medical officer.

Kerstein arrives with direct experience in the role, having previously served as CMO at both IDRx and Theseus Pharmaceuticals — a track record that matters in a seat where execution determines whether a drug program lives or dies.

What a Chief Medical Officer Actually Does The CMO — chief medical officer — is the senior physician-executive who translates a company's scientific bets into clinical trial design and regulatory strategy.

In a biotech, that job carries an outsized weight: clinical failures are the most common reason early-stage companies burn through their cash and shut down.

Keep reading

Read the full story

Open on NewsDialy